NLS-RARα promotes proliferation and inhibits differentiation in HL-60 cells

International Journal of Medical Sciences

Volumn 11, Issue 3, 2014, Pages 247-254

  Hu, Xiu Xiu ^a   Zhong, Liang ^a   Zhang, Xi ^a   Gao, Yuan Mei ^a   Liu, Bei Zhong ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Differentiation; HL 60 cell; NLS RARa; Over expression; Proliferation; shRNA

Indexed keywords

MYC PROTEIN; MYC PROTEIN, HUMAN; NUCLEAR LOCALIZATION SIGNAL; ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA-RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR ALPHA; SMALL INTERFERING RNA;

APOPTOSIS; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE TRANSLOCATION; GENETICS; HL 60 CELL LINE; HUMAN; METABOLISM; NUCLEAR LOCALIZATION SIGNAL; PATHOLOGY; PROMYELOCYTIC LEUKEMIA;

APOPTOSIS; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HL-60 CELLS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; NUCLEAR LOCALIZATION SIGNALS; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, RETINOIC ACID; RNA, SMALL INTERFERING; TRANSLOCATION, GENETIC; TRETINOIN;

EID: 84893388758     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.6518     Document Type: Article

References (30)

1. Mattei MG, Petkovich M, Mattei JF, et al. Mapping of the human retinoic acid receptor to the Q21 band of chromosome 17. Hum. Genet. 1988; 80:186-188.
2. Evans RM. The steroid and thyroid hormone receptor superfamily. Science. 1988; 240:889-895.
3. Escriva H, Bertrand S, Laudet V. The evolution of the nuclear receptor superfamily. Essays Biochem. 2004; 40:11-26. Review.
4. McEwan IJ. Nuclear receptors: one big family. Methods Mol Biol. 2009; 505:3-18.
5. Glass CK, DiRenzo J, Kurokawa R, Han ZH. Regulation of gene expression by retinoic acid receptors. DNA Cell Biol. 1991; 10:623-638. Review.
6. Rochette-Egly C, Germain P. Dynamic and combinatorial control of gene expression by nuclear retinoic acid receptors. Nucl Recepet Signal. 2009; 7:e005.
7. Gronemeyer H, Gustafsson JA, Laudet V. Principles for modulation of the nuclear receptor superfamily. Nat Rev Drug Discov. 2004; 3:950-964.
8. Aranda A, Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev. 2001; 81: 1269-1304.
9. Saurin AJ, Borden KL, Boddy MN. et al. Does this have a familiar RING? Trends Biochem Sci. 1996; 21: 208-14.
10. Kakizuka A, Miller Jr WH, Umesono K, et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell. 1991; 66:663-674.
11. Soo JY, Seob EJ, Jae HL. A complex, four-way variant t(15;17) in acute promyelocytic leukemia. Cancer Genetics and Cytogenetics. 2006; 167:168-71.
12. Pollock JL, Westervelt P, Walter MJ, et al. Mouse models of acute. Promyelocytic leukemia. Curr Opin Hematol. 2001; 8(4):206-211.
13. Laurenzana A, Pettersson F, Miller WH. Role of PML/RARα in the pathogenesis of APL. Drug Discovery Today: Disease Mechanisms. 2006; 3:499-505
14. Grisolano JL, Wesselschmidt RL, Pelicci PG, et al. Altered myeloid development and acute leukemia in transgenic mice expressing PML-RARα under control of cathepsin G regulatory sequences. Blood. 1997; 89:376-87.
15. He LZ, Tribioli C, Riv R, et al. Acute leukemia with promyelocytic features in PML/RARα transgenic mice. Proc Natl Acad Sci USA. 1997; 94:5302-7.
16. Westervelt P, Lane AA, Pollock JL, et al. High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARα expression. Blood. 2003; 102:1857-65.
17. Early E, Moore MA, Kakizuka A, et al. Transgenic expression of PML/RARα impairs myelopoiesis. Proc Natl Acad Sci USA. 1996; 93:7900-4.
18. Lane AA, Ley TJ. Neutrophil elastase cleaves PML-RARα and is important for the development of acute promyelocytic leukemia in mice. Cell.2003; 115:305-18.
19. Takahashi N. Induction of cell differentiation and development of new anticancer drugs. Yakugaku Zasshi. 2002; 122:547-563.
20. Wartman LD, Welch LJ, Uy GL, et al. Expression and function of PML-RARA in the hemotopoietic progenitor cells of Ctsg-PML-RARA mice. PLoS One. 2012; 7: e46529.
21. Hayakawa F, Privalsky ML. Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis. Cancer Cell. 2004; 5:389-401.
22. Shima Y, Shima T, et al. PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation. Mol Cell Biol. 2008; 28:7126-38.
23. Melnick A, Licht JD. Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood. 1999; 93:3167-3215.
24. Nesbit CE, Tersak JM, Prochownik EV. MYC oncogenes and human neoplastic disease. Oncogene. 1999; 18:3004-3016.
25. Vita M, Henriksson M. The Myc oncoprotein as a therapeutic target for human cancer. Semin Cancer Biol. 2006; 16:318-330.
26. Oster SK, Ho CS, Soucie EL, Penn LZ. The myc oncogene: marvelouslY complex. Adv Cancer Res. 2002; 84:81-154.
27. Eilers M, Eisenman RN. Myc's broad reach. Genes Dev. 2008; 22:2755-2766.
28. Leon J, Ferrandiz N, Acosta JC, Delgado MD. Inhibition of cell differentiation: a critical mechanism for MYC-mediated carcinogenesis? Cell Cycle. 2009; 8:1148-1157.
29. Muller-Tidow C, Steffen B, Cauvet T, Tickenbrock L, Ji P, et al. Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells. Mol Cell Biol. 2004; 24:2890-2904.
30. Rice KL, Hormaeche I, Doulatov S, et al. Comprehensive genomic screens identify a role for PLZF-RARalpha as a positive regulator of cell proliferation via direct regulation of c-MYC. Blood. 2009; 114:5499-5511.